The TP53 mutation is being observed frequently in many cancers, such as non‐small cell lung cancer,31 chronic lymphocytic leukemia,32 acute myeloid leukemia, 33 and breast cancer. This evidence concerns the gene TP53 and acute myeloid leukemia.